Of interest, a novel potential therapeutic approach in metabolic syndrome and obesity proposed the use of hormetic molecules to induce NrF2-mediatedcytoprotection against oxidative stress and inflammation [59,60]. This evidence concerns the gene NFE2L2 and metabolic syndrome.